Prazosin for Veterans with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: A Clinical Trial

Alcoholism: Clinical and Experimental Research

Volumn 40, Issue 1, 2016, Pages 178-186

  Petrakis, Ismene L ^a   Desai, Nitigna ^b   Gueorguieva, Ralitza ^c   Arias, Albert ^a   O'Brien, Erin ^a   Jane, J Serrita ^a   Sevarino, Kevin ^a   Southwick, Steven ^a   Ralevski, Elizabeth ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

Alcoholism; Clinical trial; Posttraumatic stress disorder; Prazosin; Veterans

Indexed keywords

PLACEBO; PRAZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ADVERSE OUTCOME; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP; SLEEP DISORDER; SYMPTOM; TREATMENT OUTCOME; VETERAN; INSOMNIA; MIDDLE AGED; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGY; STRESS DISORDERS, POST-TRAUMATIC;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADULT; ALCOHOLISM; DIAGNOSIS, DUAL (PSYCHIATRY); DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PRAZOSIN; SLEEP INITIATION AND MAINTENANCE DISORDERS; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME; VETERANS;

EID: 84952976898     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12926     Document Type: Article

References (45)

1. Ahmadpanah M, Sabzeiee P, Hosseini SM, Torabian S, Haghighi M, Jahangard L, Bajoghli H, Holsboer-Trachsler E, Brand S (2014) Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder. Neuropsychobiology 69:235-242.
2. Anton RF, Moak DH, Latham PK (1996) The Obsessive Compulsive Drinking Scale: a new method of assessing outcome in alcoholism treatment studies [published erratum appears in Arch Gen Psychiatry 1996 Jul; 53(7):576]. Arch Gen Psychiatry 53:225-231.
3. Arnsten AF, Raskind MA, Taylor FB, Connor DF (2015) The effects of stress exposure on prefrontal cortex: translating basic research into successful treatments for post-traumatic stress disorder. Neurobiol Stress 1:89-99.
4. Aston-Jones G, Valentino RJ, Van Bockstaele E, Meyerson A (1994) Locus coeruleus, stress, and PTSD: neurobiological and clinical parallels, in Catecholamine Function in Post-Traumatic Stress Disorder (Murburg M ed), pp 17-62. American Psychiatric Press, Washington, DC.
5. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Klauminzer G, Charney DS, Keane TM (1990) A clinician rating scale for assessing current and lifetime PTSD: the CAPS-1. Behav Ther 13:187-188.
6. Brunner E, Domhof S, Langer F (2002) Nonparametric Analysis of Longitudinal Data in Factorial Experiments. John Wiley & Sons, New York, NY.
7. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193-213.
8. First MB, Spitzer RL, Gibbon M, Williams JBW (1996) Structured Clinical Interview for DSM-IV Axis I Disorders (Patient Edition) (SCID-P). Biometric Research, New York State Psychiatric Institute, New York, NY.
9. Fox HC, Anderson GM, Tuit K, Hansen J, Kimmerling A, Siedlarz KM, Morgan PT, Sinha R (2012) Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings. Alcohol Clin Exp Res 36:351-360.
10. Friedman MJ (2013) Toward rational pharmacotherapy for posttraumatic stress disorder: reprise. Am J Psychiatry 170:944-946.
11. Froehlich JC, Hausauer BJ, Federoff DL, Fischer SM, Rasmussen DD (2013) Prazosin reduces alcohol drinking throughout prolonged treatment and blocks the initiation of drinking in rats selectively bred for high alcohol intake. Alcohol Clin Exp Res 37:1552-1560.
12. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S (2003) The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med 45:5-14.
13. Hertzberg MA, Feldman ME, Beckham JC, Kudler HS, Davidson JR (2000) Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry 12:101-105.
14. Hoge CW, Auchterlonie JL, Milliken CS (2006) Mental health problems, use of mental health services, and attrition from military service after returning from deployment to Iraq or Afghanistan. JAMA 295:1023-1032.
15. Hoge CW, Castro CA, Messer SC, McGurk D, Cotting DI, Koffman RL (2004) Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med 351:13-22.
16. Hoge CW, Terhakopian A, Castro CA, Messer SC, Engel CC (2007) Association of posttraumatic stress disorder with somatic symptoms, health care visits, and absenteeism among Iraq war veterans. Am J Psychiatry 164:150-153.
17. Institute of Medicine (2014) Treatment for Posttraumatic Stress Disorder in Military and Veteran Populations: Final Assessment. The National Academies Press, Washington, DC.
18. Kalman D, Lee A, Chan E, Miller DR, Spiro A 3rd, Ren XS, Kazis LE (2004) Alcohol dependence, other psychiatric disorders, and health-related quality of life: a replication study in a large random sample of enrollees in the Veterans Health Administration. Am J Drug Alcohol Abuse 30:473-487.
19. Kenna GA, Haass-Koffler CL, Zywiak WH, Edwards SM, Brickley MB, Swift RM, Leggio L (2015) Role of the alpha blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial. Addict Biol doi: 10.1111/adb.12275 [Epub ahead of print].
20. Landolt HP, Gillin JC (2001) Sleep abnormalities during abstinence in alcohol-dependent patients. Aetiology and management. CNS Drugs 15:413-425.
21. Lanteri C, Salomon L, Torrens Y, Glowinski J, Tassin JP (2008) Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism. Neuropsychopharmacology 33:1724-1734.
22. Le AD, Funk D, Juzytsch W, Coen K, Navarre BM, Cifani C, Shaham Y (2011) Effect of prazosin and guanfacine on stress-induced reinstatement of alcohol and food seeking in rats. Psychopharmacology 218:89-99.
23. Levine J, Schooler NR (1986) Strategies for analyzing side effect data from SAFTEE: a workshop held fall 1985 in Rockville, Maryland. Psychopharmacol Bull 22:343-356.
24. Litten RZ, Castle IJ, Falk D, Ryan M, Fertig J, Chen CM, Yi HY (2013) The placebo effect in clinical trials for alcohol dependence: an exploratory analysis of 51 naltrexone and acamprosate studies. Alcohol Clin Exp Res 37:2128-2137.
25. McCarthy E, Petrakis I (2010) Epidemiology and management of alcohol dependence in individuals with post-traumatic stress disorder. CNS Drugs 24:997-1007.
26. McCormick DA, Pape HC, Williamson A (1991) Actions of norepinephrine in the cerebral cortex and thalamus: implications for function of the central noradrenergic system. Prog Brain Res 88:293-305.
27. Milliken CS, Auchterlonie JL, Hoge CW (2007) Longitudinal assessment of mental health problems among active and reserve component soldiers returning from the Iraq war. JAMA 298:2141-2148.
28. Nader K, LeDoux JE (1999) Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations. Behav Neurosci 113:891-901.
29. O'Neil ML, Beckwith LE, Kincaid CL, Rasmussen DD (2013) The alpha1-adrenergic receptor antagonist, doxazosin, reduces alcohol drinking in alcohol-preferring (P) Rats. Alcohol Clin Exp Res 37:202-212.
30. Patkar AA, Gopalakrishnan R, Naik PC, Murray HW, Vergare MJ, Marsden CA (2003) Changes in plasma noradrenaline and serotonin levels and craving during alcohol withdrawal. Alcohol Alcohol 38:224-231.
31. Petrakis IL, Ralevski E, Desai N, Trevisan L, Gueorguieva R, Rounsaville B, Krystal JH (2012) Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology 37:996-1004.
32. Pettinati H, Weiss R, Miller W, Donovan D, Rounsaville B (2000) Medical Management Treatment Manual Unpublished Manual. COMBINE. National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
33. Raskind MA, Peskind ER, Millard S, Petire EC (2014) Baseline blood pressure is associated with PTSD symptom response to prazosin in active duty combat soldiers. Paper Presented to the American College of Neuropsychopharmacology, Phoenix, AZ, December 7-11.
34. Rasmussen DD, Alexander LL, Raskind MA, Froehlich JC (2009) The alpha1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) rats. Alcohol Clin Exp Res 33:264-272.
35. Rasmussen DD, Wilkinson CW, Raskind MA (2006) Chronic daily ethanol and withdrawal: 6. Effects on rat sympathoadrenal activity during "abstinence." Alcohol 38:173-177.
36. Riggs DS, Rukstalis M, Volpicelli JR, Kalmanson D, Foa EB (2003) Demographic and social adjustment characteristics of patients with comorbid posttraumatic stress disorder and alcohol dependence: Potential pitfalls to PTSD treatment. Addict Behav 28:1717-1730.
37. Roth T, Roehrs T, Zorick F, Conway W (1985) Pharmacological effects of sedative-hypnotics, narcotic analgesics, and alcohol during sleep. Med Clin North Am 69:1281-1288.
38. Seda G, Sanchez-Ortuno MM, Welsh CH, Halbower AC, Edinger JD (2015) Comparative meta-analysis of prazosin and imagery rehearsal therapy for nightmare frequency, sleep quality, and posttraumatic stress. J Clin Sleep Med 11:11-22.
39. Simpson TL, Malte CA, Dietel B, Tell D, Pocock I, Lyons R, Varon D, Raskind M, Saxon AJ (2015) A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res 39:808-817.
40. Simpson TL, Saxon AJ, Meredith CW, Malte CA, McBride B, Ferguson LC, Gross CA, Hart KL, Raskind M (2009) A pilot trial of the alpha-1 adrenergic antagonist, prazosin for alcohol dependence. Alcohol Clin Exp Res 33:255-263.
41. Skinner HA, Horn JL (1984) Alcohol Dependence Scale (ADS): User's Guide. Addiction Research Foundation, Toronto, ON.
42. Sobell LC, Sobell MB (1992) Timeline Follow-Back: A technique for assessing self-reported alcohol consumption, in Measuring Alcohol Consumption: Psychosoical and Biological Methods (Litten RZ, Allen J eds), pp 41-72. Humana Press, Totowa, NJ.
43. Southwick SM, Bremner JD, Rasmusson A, Morgan CA 3rd, Arnsten A, Charney DS (1999) Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry 46:1192-1204.
44. Verplaetse TL, Rasmussen DD, Froehlich JC, Czachowski CL (2012) Effects of prazosin, an alpha1-adrenergic receptor antagonist, on the seeking and intake of alcohol and sucrose in alcohol-preferring (P) rats. Alcohol Clin Exp Res 36:881-886.
45. Walker BM, Rasmussen DD, Raskind MA, Koob GF (2008) alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol. Alcohol 42:91-97.